Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
(4R)-3-[2-(4-chlorophenoxy)-2-methylpropanoyl]-1,3-thiazolidine-4-carboxylic acid
(4R)-3-[2-(4-chlorophenoxy)-2-methylpropanoyl]-1,3-thiazolidine-4-carboxylic acid
CAS No. 1307909-30-3
(4R)-3-[2-(4-chlorophenoxy)-2-methylpropanoyl]-1,3-thiazolidine-4-carboxylic acid( —— )
Catalog No. M28466 CAS No. 1307909-30-3
(4R)-3-[2-(4-chlorophenoxy)-2-methylpropanoyl]-1,3-thiazolidine-4-carboxylic acid is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 61 | In Stock |
|
| 2MG | 34 | In Stock |
|
| 5MG | 57 | In Stock |
|
| 10MG | 86 | In Stock |
|
| 25MG | 147 | In Stock |
|
| 50MG | 216 | In Stock |
|
| 100MG | 312 | In Stock |
|
| 200MG | 435 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(4R)-3-[2-(4-chlorophenoxy)-2-methylpropanoyl]-1,3-thiazolidine-4-carboxylic acid
-
NoteResearch use only, not for human use.
-
Brief Description(4R)-3-[2-(4-chlorophenoxy)-2-methylpropanoyl]-1,3-thiazolidine-4-carboxylic acid is a chemical compound.
-
Description(4R)-3-[2-(4-chlorophenoxy)-2-methylpropanoyl]-1,3-thiazolidine-4-carboxylic acid is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorEGFR|KDR|Lck|Src|v-Abl
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1307909-30-3
-
Formula Weight329.8
-
Molecular FormulaC14H16ClNO4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(Oc1ccc(Cl)cc1)C(=O)N1CSC[C@H]1C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
VSV-G Peptide
VSV-G Peptide is a 11 amino acid peptide derived from the Vesicular Stomatitis viral glycoprotein.
-
Cbz-NH-PEG1-CH2COOH
Cbz-NH-PEG1-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
fulvotomentoside A
Fulvotomentoside A could decrease overexpression of IL-6 and IL-17A, and increase the expression of specific transcription factor Foxp3 of regulatory T cells significantly in intestine.
